This dual role of TNF-α underscores the need to balance its pro-inflammatory and anti-tumor functions when evaluating the long-term cancer risk associated with TNF inhibitor therapy in autoimmune diseases [22]. The gene discussed is TNF; the disease is autoimmune disease.